HMGA1 Drives Chemoresistance in Esophageal Squamous Cell Carcinoma by Suppressing Ferroptosis

Investigators demonstrated that ferroptosis triggered by inhibiting high mobility group AT-hook 1 (HMGA1) may provide a novel opportunity to gain an effective therapeutic strategy against chemoresistance in esophageal squamous cell carcinoma.